AWS Summit: A Peek at the ‘One FDA’ Plan to Modernize Tech Procurement
Acquisition leader Joseph Montgomery shares how AI and cloud technologies informed the agency’s new strategy.
The Food and Drug Administration recently released a new acquisition strategy that aims to transform how the agency buys technology to impact multiple mission areas. In an interview with FDA Office of Enterprise Portfolio Management Director Joseph Montgomery at AWS Summit, he highlights the importance of this strategy to create a “one FDA” ecosystem that prioritizes advanced technology and keeping pace with IT innovation.
Montgomery also highlights how he’s thinking about artificial intelligence, cybersecurity and cloud to impact financial operations (FinOps) and ultimately support FDA’s modernization goals.
Check out our full conference coverage.
This is a carousel with manually rotating slides. Use Next and Previous buttons to navigate or jump to a slide with the slide dots
-
Federal Health Leaders Explore Guardrails for AI
NIH, NCI and industry leaders discuss AI governance, data security and safeguards for deploying AI in federal health systems.
37m watch Partner Content -
What's Next For Tech, AI, Data Centers after the Midterms?
A Democratic majority in Congress and key gubernatorial victories could reshape the regulatory landscape for AI and data centers.
3m read -
Here's What's Going on With Government's ‘Super Intelligence’ Term
Federal agencies are replacing AI with "super intelligence" under a White House order. Here's how agencies and tech companies are responding.
3m read -
CMS Deploys AI Tools to Improve Security, Privacy
AI-powered tools and bug bounty programs help CMS detect threats and protect sensitive data.
7m watch
